510(k) Report

510(k) · Cleared

Cleared

Vitrea CT Brain Perfusion

K181247510(k) TraditionalCleared Nov 20, 2018194-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vital Images, Inc. · LLZ System, Image Processing, Radiological

Cleared on Nov 20, 2018 as substantially equivalent to K121213 (Vital Images, Inc., 2012) after a 194-day review. Its family tree reaches back 12 generations to 1991.

Decided
Nov 20, 2018
Review
194 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 12 generations to K913770 (1991). 100 ancestors in all, the oldest K871859 (1987). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2009: 1 other ancestor2008: 1 other ancestor2007: 2 other ancestors2005: 6 other ancestors2006: 3 other ancestors2004: 8 other ancestors2003: 7 other ancestors2002: 9 other ancestors2001: 12 other ancestors1999: 2 other ancestors1998: 6 other ancestors1996: 5 other ancestors2000: 5 other ancestors1997: 5 other ancestors1995: 4 other ancestors1991: 2 other ancestors1988: 2 other ancestors1994: 5 other ancestors1993: 2 other ancestors1987: 1 other ancestorReference device: K152602 · Olea Sphere V3.0 · Olea Medical · 2016K913770 · Advantage V.S. CT/MR Rad Diagnostic Workstation · General Electric Co. · 1991K960613 · GE Advantage Windows Review Workstation · GE Medical Systems · 1996K020483 · Advantage Workstation 4.1 · GE Medical Systems · 2002 · recalledK023003 · Imagechecker-CT Workstation · R2 Technology, Inc. · 2002×2: 2 generations cleared close together, K032748 (2003), K040305 (2004) K043333 · VITREA2, Version 3.7 Medical Image Processing System · Vital Images, Inc. · 2004 · recalledK052632 · VITREA2 Version 3.8 Medical Image Processing Software · Vital Images, Inc. · 2005 · recalledK061624 · Vitrea, Version 3.9 · Vital Images, Inc. · 2006 · recalledK071331 · Vitrea Version 4.0 · Vital Images, Inc. · 2007 · recalledK072821 · Vitrea 4DCT · Vital Images, Inc. · 2008 · recalledK121213 · Vitreaadvanced · Vital Images, Inc. · 2012 · recalled19851990199520002005201020152020
  1. Root · 12 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 8 generations between
  3. 3 generations backK071331 Vitrea Version 4.0Vital Images, Inc. · 2007 · Recalled
  4. 2 generations backK072821 Vitrea 4DCTVital Images, Inc. · 2008 · Recalled
  5. 1 generation backK121213 VitreaadvancedVital Images, Inc. · 2012 · Recalled
  6. This deviceK181247 Vitrea CT Brain PerfusionVital Images, Inc. · 2018
Show all 12 generations
  1. Root · 12 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 11 generations backK960613 GE Advantage Windows Review WorkstationGE Medical Systems · 1996
  3. 10 generations backK020483 Advantage Workstation 4.1GE Medical Systems · 2002 · Recalled
  4. 9 generations backK023003 Imagechecker-CT WorkstationR2 Technology, Inc. · 2002
  5. 8 generations backK032748 VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc. · 2003 · Recalled
  6. 7 generations backK040305 VITREA2 Version 3.5Vital Images, Inc. · 2004
  7. 6 generations backK043333 VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc. · 2004 · Recalled
  8. 5 generations backK052632 VITREA2 Version 3.8 Medical Image Processing SoftwareVital Images, Inc. · 2005 · Recalled
  9. 4 generations backK061624 Vitrea, Version 3.9Vital Images, Inc. · 2006 · Recalled
  10. 3 generations backK071331 Vitrea Version 4.0Vital Images, Inc. · 2007 · Recalled
  11. 2 generations backK072821 Vitrea 4DCTVital Images, Inc. · 2008 · Recalled
  12. 1 generation backK121213 VitreaadvancedVital Images, Inc. · 2012 · Recalled
  13. This deviceK181247 Vitrea CT Brain PerfusionVital Images, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K913770Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co.1991—
−11K960613GE Advantage Windows Review WorkstationGE Medical Systems1996—
−10K020483Advantage Workstation 4.1GE Medical Systems20022
−9K023003Imagechecker-CT WorkstationR2 Technology, Inc.2002—
−8K032748VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc.20032
−7K040305VITREA2 Version 3.5Vital Images, Inc.2004—
−6K043333VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc.20041
−5K052632VITREA2 Version 3.8 Medical Image Processing SoftwareVital Images, Inc.20052
−4K061624Vitrea, Version 3.9Vital Images, Inc.20061
−3K071331Vitrea Version 4.0Vital Images, Inc.20071
−2K072821Vitrea 4DCTVital Images, Inc.20081
−1K121213VitreaadvancedVital Images, Inc.20121
0 (this device)K181247Vitrea CT Brain PerfusionVital Images, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
198820
199120
199320
199450
199540
199650
199750
199860
199920
200050
2001120
200290
200370
200480
200560
200630
200720
200810
200910
FIG. 1 — Lineage of K181247, 1991–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121213Vitreaadvanced
Summary page 4
…notification submission for proposed software changes in the already Submission: 510(k) cleared Vitrea CT Brain Perfusion software (K121213). Vital Images, Inc. Submitter: 5850 Opus Parkway, Suite 300 M…
Vital Images, Inc.20121
†K152602Olea Sphere V3.0Olea Medical2016—

Also cleared against K121213: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 4 companies; a new generation was cleared every 11 months on median.
  • 29 of the 100 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K121213.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

Vitrea CT Brain Perfusion is a non-invasive post-processing application designed to evaluate areas of brain perfusion. The software can calculate cerebral blood flow (CBF), cerebral blood volume (CBV), local bolus timing (i.e., delay of tissue response, time to peak), and mean transit time (MTT) from dynamic CT image data acquired after the injection of contrast media. The package also allows the calculation of regions of interest and mirrored regions…

Read the full statement (131 words)

Vitrea CT Brain Perfusion is a non-invasive post-processing application designed to evaluate areas of brain perfusion. The software can calculate cerebral blood flow (CBF), cerebral blood volume (CBV), local bolus timing (i.e., delay of tissue response, time to peak), and mean transit time (MTT) from dynamic CT image data acquired after the injection of contrast media. The package also allows the calculation of regions of interest and mirrored regions, as well as the visual inspection of time density curves. Vitrea CT Brain Perfusion supports the physician in visualizing the apparent blood perfusion in brain tissue affected by acute stroke. Areas of decreased perfusion, as is observed in acute cerebral infarcts, appear as areas of changed signal intensity (lower for both CBF and CBV and higher for time to peak and MTT).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K181247: Vitrea CT Brain Perfusion.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K181247

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026